Charles Sherwood, CEO of Anika Therapeutics (NASDAQ: [[ticker:ANIK]]), is retiring from the company and its board of directors after nearly 20 years. Joseph Darling, Anika’s president, will succeed Sherwood as CEO of the Bedford, MA company. Darling, who came to Anika last July, will also join the company’s board of directors. Anika develops and markets products for pain management, tissue regeneration, and wound healing.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
